Bibliografia UJ CM




Zapytanie: CARRIE DIDIER
Liczba odnalezionych rekordów: 8



Przejście do opcji zmiany formatu | Wyświetl/ukryj etykiety | Wersja do druku | | | Nowe wyszukiwanie
1/8
Yuichi Saito, Ecaterina Cristea, Georgios Bouras, Alexandre Abizaid, Matthias Lutz, Didier Carrie, Joachim Weber-Albers, Darius Dudek, Jeffrey Anderson, Alexandra Lansky.
Long-term serial functional evaluation after implantation of the Fantom sirolimus-eluting bioresorbable coronary scaffold.
Catheterization and Cardiovascular Interventions
2021 : Vol. 97, nr 3, s. 431-436, il., bibliogr. 21 poz., abstr.
Autor korespondencyjny: Alexandra Lansky.
p-ISSN: 1522-1946

AZ
ORG
AIF
IF: 2.585
Adres url:
Streszczenie w PubMed:
2/8
Yoshinobu Onuma, Bernard Chevalier, Masafumi Ono, Angel Cequier, Dariusz Dudek, Michael Haude, Didier Carrie, Manel Sabate, Stephan Windecker, Richard Rapoza, Nick E.J. West, Sebastian Reith, Manuel de Sousa Almeida, Gianluca Campo, Andres Iniguez, Patrick W. Serruys.
Bioresorbable scaffolds versus everolimus-eluting metallic stents : Five years clinical outcomes of the randomised ABSORB II trial.
Eurointervention
2020 : Vol. 16, nr 11, s. e938-e941, il., bibliogr. 7 poz., abstr.
Autor korespondencyjny: Patrick W. Serruys.
p-ISSN: 1774-024X

AZ
ORG
AIF
IF: 6.534
Adres url:
Streszczenie w PubMed:
3/8
Bernard Chevalier, Alexandre Abizaid, Didier Carrie, Norbert Frey, Matthias Lutz, Joachim Weber-Albers, Darius Dudek, Shu-Chuan Weng, Mariama Akodad, Jeffrey Anderson, Gregg W. Stone.
Clinical and Angiographic Outcomes With a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold.
Circulation. Cardiovascular Interventions
2019 : Vol. 12, nr 6 art. no. e007283, s. 1-8, il., bibliogr. 21 poz.
Autor korespondencyjny: Bernard Chevalier.
Open Access Creative Commons Attribution License CC-BY-NC 4.0.

p-ISSN: 1941-7640

AZ
ORG
AIF
IF: 5.493
Adres url:
Streszczenie w PubMed:
4/8
Jo Krogsgaard Simonsen, Emil Nielsen Holck, Didier Carrie, Norbert Frey, Matthias Lutz, Joachim Weber-Albers, Dariusz Dudek, Bernard Chevalier, Joost Daemen, Jouke Dijkstra, Camilla Fox Maule.
Mechanical performance and healing patterns of the novel sirolimus-eluting bioresorbable Fantom scaffold: : 6-month and 9-month follow-up by optical coherence tomography in the FANTOM II study.
Open Heart
2019 : Vol. 6, nr 1, e000941, il., bibliogr. 21 poz., abstr.
Autor korespondencyjny: Niels Ramsing Holm.
Open Access Creative Commons Attribution License CC-BY

p-ISSN: 2053-3624

AZ
ORG
APZ
Adres url:
Streszczenie w PubMed:
DOI:
5/8
Bernard Chevalier, Angel Cequier, Dariusz Dudek, Michael Haude, Didier Carrie, Manel Sabate, Stephan Windecker, Sebastian Reith, Manuel de Sousa Almeida, Gianluca Campo, Andres Iniguez, Yoshi Onuma, Patrick W. Serruys.
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II trial).
Eurointervention
2018 : Vol. 13, nr 13, s. 1561-1564
Autor korespondencyjny: brak.
p-ISSN: 1774-024X

AZ
ORG
AIF
IF: 4.018
Adres url:
Streszczenie w PubMed:
DOI:
6/8
Alexandre Abizaid, Didier Carrie, Norbert Frey, Matthias Lutz, Joachim Weber-Albers, Darius Dudek, Bernard Chevalier, Shu-Chuan Weng, Ricardo A. Costa, Jeffrey Anderson, Gregg W. Stone.
6-Month Clinical and Angiographic Outcomes of a Novel Radiopaque Sirolimus-Eluting Bioresorbable Vascular Scaffold: The FANTOM II Study.
JACC. Cardiovascular Interventions
2017 : Vol. 10, nr 18, s. 1832-1838, il., bibliogr. 20 poz., abstr.
Autor korespondencyjny: Alexandre Abizaid.
p-ISSN: 1936-8798

AZ
ORG
AIF
IF: 9.881
Adres url:
Streszczenie w PubMed:
7/8
Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi, Angel Cequier, Didier Carrie, Jan J. Piek, Ad J. van Boven, Marcello Dominici, Dariusz Dudek, Dougal McClean, Steffen Helqvist, Michael Haude, Sebastian Reith, Manuel de Sousa Almeida, Gianluca Campo, Andrés Iniguez, Manel Sabate, Stephan Windecker, Yoshinobu Onum.
Comparison of an everolimus-eluting bioresorbable scaff old with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial.
Lancet
2016 : Vol. 388, nr 10059, s. 2479-2491, il., bibliogr. 27 poz., summ.
p-ISSN: 0140-6736

AZ
ORG
AIF
IF: 47.831
Adres url:
Streszczenie w PubMed:
8/8
Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek, Angel Cequier, Didier Carrie, Andres Iniguez, Marcello Dominici, Rene J. van der Schaaf, Michael Haude, Luc Wasungu, Susan Veldhof, Lei Peng, Peter Staehr, Maik J. Grundeken, Yuki Ishibashi, Hector M. Garcia-Garcia, Yoshinobu Onuma.
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial.
Lancet
2015 : Vol. 385, nr 9962, s. 43-54, il., bibliogr. 36 poz., sum.
p-ISSN: 0140-6736

AZ
ORG
AIF
IF: 44.002
  Wyświetl ponownie stosując format:
Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ